Drug discovery

#Drug activity #Drug development #Drug discovery #GPCR

Webinar: Revealing hidden pharmacology with GPCR assays

The pharmacological behaviour of drugs is determined not only by their intrinsic properties but also by the sensitivity of the biological systems in which they are evaluated. Variations in receptor density and signal transduction efficiency can significantly influence observed drug responses, complicating the translation of in vitro findings to in… Read More

#News

#Advertorial #ApconiX #Central nervous system #Drug discovery #Neuroscience

Mitigating ion channel related CNS liability in novel compounds by predicting SAR

In this paid-for advertorial for the Fall 2026 issue of DDW. The ApconiX team are working towards providing a high throughput service to resolve central nervous system (CNS) liabilities earlier in the drug discovery pipeline. Their recently published study is the first reported method to use structure… Read More

#Exclusive Content

#Carterra #Drug discovery #Lab in the loop #Small molecules

Carterra advances lab-in-the-loop drug discovery  

Carterra, a provider of high-throughput surface plasmon resonance (HT-SPR) platforms for antibody and small molecule drug discovery, has collaborated with AstraZeneca to develop hardware and software aimed at advancing lab-in-the loop drug discovery.   Lab-in-the-loop – the model in which AI systems propose drug candidates, wet-lab experiments generate… Read More

#News

Lipid nanoparticle siRNA antivirals
#cryo-microscopy #Drug discovery #Imaging #Lipid based nanoparticle (LNP)

Advancing LNP-based vaccines with cryo-TEM and automated image analysis

This new Whitepaper, sponsored by ThermoFisher Scientific, explores a scalable workflow for directly visualising LNPs in their near-native state and measuring critical quality attributes to support formulation optimisation, process development, and consistent therapeutic and vaccine delivery. Download now to: See beyond bulk measurements: Learn how cryo-TEM directly visualises individual LNPs in… Read More

#News

#Drug discovery #Eye health #Genetics #Inherited blindness

Gene linked to inherited blindness discovered

Faults in a gene known for causing a devastating childhood metabolic illness can also cause a form of inherited blindness in adults, an international study co-led by scientists at the University of Manchester, University College London and the Greenwood Genetic Center in the US has found. In the first study… Read More

#News

#Cell and gene therapy #Cell therapy #Drug discovery #Webinar

Webinar: Advances and challenges in cell & gene therapies

Hosted by Drug Discovery World and supported by Bio-Techne this webinar will explore the advances and challenges taking place within the cell and gene therapy field. You will hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo… Read More

#News

#Cancer research #Cancer vaccines #Drug development #Drug discovery #Immuno-oncology #Sino Biological

Summit: What advances are driving immuno-oncology drug discovery?

This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. It will take place on Wednesday, October 21, 2026 at 7am PDT / 10am EDT / 3pm BST / 4pm CEST. Featuring expert presentations and a panel… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Rare disease #Technology #Tumours

This week in Drug Discovery (12-16 October)

News round-up for 12-16 October 2026 by Megan Thomas, Multimedia Editor at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Conference in London, as well as new initiatives to accelerate rare disease drug development, promising preclinical data for Duchenne muscular dystrophy, clinical trial… Read More

#News

Immunotherapy
#Cancer research #Cancer vaccines #Drug development #Drug discovery #Immuno-oncology #Sino Biological

Register now for immuno-oncology summit

This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. It will take place on Wednesday, October 21, 2026 at 7am PDT / 10am EDT / 3pm BST / 4pm CEST. Featuring expert presentations and a panel… Read More

#News

#Biotech #Drug discovery #Funding #Investment

3 key takes from Optimum’s Investor Conference

DDW Editor Reece Armstrong offers three key takeaways from Optimum’s Annual Healthcare Investor Conference.  AI is still dominating the conversation AI was an obvious talking point throughout the conference, with its application in both investing and in drug discovery and development being major points of discussion. As someone who regularly… Read More

#Exclusive Content

Basel map
#Academic #Biotech #Drug development #Drug discovery #Life sciences

How the right environment accelerates biotech innovation

Christof Klöpper, CEO of Basel Area Business and Innovation, discusses how ecoystems for biotech can advance innovation and how the Basel area is an example of an impressive concentration of talent.  A decade ago, the typical formula for biotech locations went something like this: emerge from an academic institution or… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Bioinformatics #Drug discovery #Genomics #QUIAGEN

QIAGEN expands AI-powered bioinformatics for research and drug discovery   

QIAGEN’s new artificial intelligence (AI) capabilities will reportedly help researchers analyse complex biological and genomic data faster while keeping the scientific evidence behind the results visible.  The expansion includes IPA Investigator, a new AI research companion for QIAGEN Ingenuity Pathway Analysis (IPA), and the new QIAGEN Discovery… Read More

#News

mRNA
#Drug discovery #eBook #Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines

Discover mRNA: Beyond vaccines to personalised medicine

Despite a challenging funding landscape, 2026 has seen two groundbreaking advances in mRNA vaccine discovery; the first-ever mRNA seasonal influenza vaccine for adults and the first positive Phase III readout for an mRNA-based cancer therapy. This eBook explores how the mRNA platform has evolved since its use in Covid-19 vaccines,… Read More

#News